Use of hypnotics and sedatives

RX_N05C

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N05C

88058

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

54303

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

54303

diagram downward connector

Include endpoints None

54303

diagram downward connector
RX_N05C

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 52509 31558 20951
Unadjusted prevalence (%) 17.02 18.19 15.52
Mean age at first event (years) 52.43 51.00 54.59

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.89 [1.71, 2.09] 2.8e-35 8020
15 years 0.01 1.38 [1.26, 1.51] 2.0e-12 4160
5 years 0.00 2.08 [1.92, 2.27] 5.3e-65 1868
1 year 0.00 2.16 [1.87, 2.50] 6.8e-25 378

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_N05C – Use of hypnotics and sedatives
GWS hits:

Survival analyses between endpoints

Plot

before Use of hypnotics and sedatives
after Use of hypnotics and sedatives

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of hypnotics and sedatives